Pablo compared with Amadeo after stroke
2026
RCT
Comparison of proprioceptive stimulation with robotic mechanotherapy (Pablo/Amadeo) in stroke patients
Quasi-randomised controlled trial. Devices: Pablo and Amadeo (Tyromotion, Austria). BMC Sports Science, Medicine and Rehabilitation, 2026.
What does this mean for our patients?
The comparison helps us match the choice of device to the individual picture rather than using one device across the board.
Read the original article →
Diego in cervical spinal cord injury
2025
Research
Feasibility of the Diego system in people with cervical spinal cord injury
Mixed-methods pilot study, 7 participants. Device: Diego (Tyromotion, Austria). Disability and Rehabilitation, 2025.
What does this mean for our patients?
With high spinal cord injuries and limited arm function, safe, guided training is decisive. This feasibility study strengthens our use of Diego in more complex cases too.
Read the original article →
Lexo in various neurological conditions
2024
Research
Robot-assisted gait training in various neurological conditions: a feasibility study
Mixed-methods feasibility study, 28 participants (stroke, MS, Parkinson’s, spinal cord injury, ataxia, CIDP, ALS). Device: Lexo (Tyromotion, Austria). PLOS ONE, 2024.
What does this mean for our patients?
We find it particularly valuable that this study covers several of our core conditions — from stroke to spinal cord injury. It confirms the broad use of Lexo in our daily practice.
Read the original article →
Amadeo hand rehabilitation
2023
Research
Assessment of finger strength and spasticity in hemiplegic patients using a hand and finger robot
Validity and reliability study, 161 participants (107 patients, 54 controls). Device: Amadeo (Tyromotion, Austria). 2023.
What does this mean for our patients?
The reliability of the Amadeo system lets us measure progress in hand function objectively — not just estimate it. That helps us adjust therapy precisely.
Read the original article →
Amadeo spasticity measurement
2023
Research
Spasticity measurement with the Amadeo device in stroke patients
Validation study, 20 stroke patients and 20 healthy controls. Device: Amadeo (Tyromotion, Austria). 2023.
What does this mean for our patients?
An objective measure of spasticity makes it easier for us to follow progress and to coordinate with our patients’ doctors, for example before botulinum toxin treatment.
Read the original article →
Lyra gait training after stroke
n.d.
RCT
Electromechanically assisted gait training with the Lyra device in subacute stroke
Randomised, controlled, single-blind trial, 72 participants planned. Device: Lyra (manufacturer THERA-Trainer, not Tyromotion).
What does this mean for our patients?
Electromechanically assisted gait training allows far more repetitions per session than conventional practice — particularly valuable in the early phase after a stroke.
Read the original article →
There is no published work for this selection in this area.